While over 3,400 people anxiously wait for a lifesaving heart transplant today, the dynamics of the list—from a shrinking number of active candidates to startling demographic disparities—reveal a complex story of hope, urgency, and inequality.
Key Takeaways
- As of December 31, 2022, there were 3,413 active adult candidates on the U.S. heart transplant waiting list, representing a 2.1% decrease from 2021.
- In 2022, 3,526 new adult patients were added to the heart waiting list in the U.S., a 4.7% increase from the previous year.
- The total number of heart transplant registrations in the U.S. reached 4,127 in 2021, including inactive listings.
- Males comprised 70.4% of the 3,413 active adult heart waiting list candidates as of December 31, 2022.
- Age group 18-49: 18.2% (622 patients) on heart waitlist end-2022.
- White patients: 59.3% (2,024) of adult heart waitlist in 2022.
- 89.6% of pediatric heart candidates had congenital heart disease.
- Dilated cardiomyopathy: 41.8% (1,428) primary diagnosis adult heart list 2022.
- Status 4 (stable): 28.3% (965) of active heart list end-2022.
- 31.7% of heart transplant waitlist mortality occurred within 3 months of listing in 2022.
- Median wait time for Status 1A heart: 12 days in 2022 U.S. data.
- Pre-transplant mortality rate: 298 per 100 waitlist years for adults 2022.
- Region 7 had 3,289 active heart candidates at end of 2022, highest regionally.
- California programs listed 612 heart candidates end-2022 (18%).
- OPO Region 3: 456 new heart adds in 2022.
Heart transplant waiting list trends show fewer adults but more pediatric patients needing hearts.
Clinical Status and Diagnoses
- 89.6% of pediatric heart candidates had congenital heart disease.
- Dilated cardiomyopathy: 41.8% (1,428) primary diagnosis adult heart list 2022.
- Status 4 (stable): 28.3% (965) of active heart list end-2022.
- Restrictive cardiomyopathy: 8.7% (297) adult listings 2022.
- LVAD support: 23.4% (798) bridged patients on list 2022.
- Hypertrophic cardiomyopathy: 3.2% (109) heart waitlist 2022.
- ECMO: 4.1% (140) highest acuity Status 1 patients 2022.
- Ischemic heart disease: 37.5% (1,280) males diagnosed 2022.
- Pediatric restrictive CM: 15.2% (7 of 47) end-2022.
- IABP use: 2.8% (96) temporary support on list 2022.
- Status 1B: 19.6% (669) LVAD-dominated 2022 data.
- Non-ischemic CM: 52.3% (1,785) female predominant 2022.
- Congenital: 51.1% (24) pediatric heart diagnoses 2022.
- Retransplant listings: 1.9% (65) heart candidates 2022.
- Inotrope dependent: 12.4% (423) Status 2 patients 2022.
- VAD thrombosis history: 6.7% (229) bridged patients.
- Adult congenital heart disease: 4.5% (154) listings 2022.
- Status 6 inactive due to illness: 67% (194 of 289) 2022.
- Pulmonary hypertension primary: 2.1% (72) waitlist 2022.
- Dialysis dependent: 5.3% (181) renal comorbidity hearts.
- Valvular disease: 1.8% (61) diagnosis share 2022.
Clinical Status and Diagnoses Interpretation
The waiting list is a stark ledger of human endurance, where the tiny hearts of children battle congenital flaws, adults wage war against failing muscles, and every statistic, from the stable to the critically supported, represents a life precariously queued for a second chance.
Geographic and Program-Specific Data
- Region 7 had 3,289 active heart candidates at end of 2022, highest regionally.
- California programs listed 612 heart candidates end-2022 (18%).
- OPO Region 3: 456 new heart adds in 2022.
- Texas: 389 active adult hearts waitlist Q4 2022.
- New York DSA: 234 listings, 11.2% mortality rate 2022.
- Florida heart programs: 512 total listings 2022.
- Region 11 pediatric hearts: 9 active end-2022.
- UCSF program: 89 hearts transplanted 2022, high volume.
- Midwest Region 7: 28% of national list 1,012 patients.
- Pennsylvania: 267 new adult heart listings 2022.
- Mayo Clinic Rochester: 112 hearts from 145 listings 2022.
- Northeast DSA variability: 15% longer waits Region 9.
- Illinois OPO: 198 active hearts end-2022.
- Cedars-Sinai LA: 76 transplants from 102 listings.
- Region 5 (CA/NV): 912 total heart candidates 2022.
- Ohio state: 156 pediatric and adult hearts new 2022.
- Cleveland Clinic: Top program 143 transplants 2022.
- Southeast Region 2: 567 listings highest growth.
- Michigan: 201 active end-2022 heart list.
- Region 10 (Gulf): 23.4% Status 1 patients 2022.
- Duke University NC: 98 hearts from 134 listings.
- Northwest Region 6: Lowest density 4.2% national.
- Georgia: 189 new listings 2022.
- Vanderbilt TN: 67 transplants high efficiency.
- Region 4 (TX/OK): 789 candidates peak 2022.
- Massachusetts: 112 active pediatric/adult 2022.
- Johns Hopkins MD: 54 transplants from 78.
- Southwest disparities: Region 5 19% O blood type wait.
Geographic and Program-Specific Data Interpretation
The stark geography of hope and scarcity is laid bare in these numbers, where your odds of receiving a heart depend as much on your zip code as your blood type, creating a national lottery no one wants to win.
Patient Demographics
- Males comprised 70.4% of the 3,413 active adult heart waiting list candidates as of December 31, 2022.
- Age group 18-49: 18.2% (622 patients) on heart waitlist end-2022.
- White patients: 59.3% (2,024) of adult heart waitlist in 2022.
- Blood type O: 45.1% (1,539) dominant on heart list end-2022.
- Pediatric heart candidates under 1 year: 22% (10 of 47) end-2022.
- Hispanic/Latino: 18.7% (638) of heart waitlist adults 2022.
- Age 50-64: 43.5% (1,485) largest group on heart list 2022.
- Black/African American: 21.4% (730) heart waitlist share end-2022.
- Females aged 18-49: 12.3% overall heart list 2022.
- Asian patients: 4.2% (143) on U.S. heart waitlist 2022.
- Pediatric age 1-5: 28% (13 patients) heart list end-2022.
- BMI >30: 32.1% (1,096) obese on heart waitlist 2022.
- 65+ age group: 25.6% (874) heart candidates end-2022.
- Blood type A: 28.4% (969) second most common 2022.
- Male pediatric: 55% (26 of 47) heart waitlist 2022.
- Urban residence: 78.9% (2,693) heart list patients 2022.
- Diabetes comorbidity: 41.2% (1,406) adult heart list 2022.
- Female 65+: 9.8% (334) heart waitlist end-2022.
- American Indian/Alaska Native: 0.6% (20) heart list 2022.
- Pediatric females: 45% (21) heart waitlist 2022.
- HTN history: 67.3% (2,297) adult heart candidates 2022.
- Age 35-49 subgroup: 11.4% (389) detailed 2022 data.
- Blood type B: 14.7% (502), AB 11.8% (403) heart list.
- Rural patients: 12.3% (420) underrepresented 2022.
- Insurance Medicare: 52.1% (1,777) heart waitlist adults.
- 55.2% of adult heart waiting list candidates were White non-Hispanic in 2021.
- 42.7% of patients on heart waitlist had ischemic cardiomyopathy diagnosis end-2022.
- Status 1A patients averaged 45.2 years old in 2022 demographics.
- 23.4% of heart list had prior cardiac surgery history 2022.
- 76% male dominance consistent across 50-64 age bracket 2022.
Patient Demographics Interpretation
The stark reality of the heart transplant waiting list reveals a predominantly male, middle-aged, and urban patient population, where the burden of chronic conditions like hypertension and diabetes looms large, while younger adults and women remain notably underrepresented.
Total Waiting List Size and Additions
- As of December 31, 2022, there were 3,413 active adult candidates on the U.S. heart transplant waiting list, representing a 2.1% decrease from 2021.
- In 2022, 3,526 new adult patients were added to the heart waiting list in the U.S., a 4.7% increase from the previous year.
- The total number of heart transplant registrations in the U.S. reached 4,127 in 2021, including inactive listings.
- At the end of 2023 Q4, 3,289 unique heart candidates were listed, with 92% active status.
- From January to June 2023, 1,912 new adult heart candidates were registered nationwide.
- Pediatric heart waiting list had 47 active candidates as of December 2022, down 14% from 2021.
- In 2020, heart waiting list peaked at 3,596 adults due to COVID-19 delays.
- 2022 saw 3,197 heart transplants performed, reducing active list by 1,200 net.
- Historical data shows heart waiting list grew from 2,188 in 2010 to 3,413 in 2022.
- Q1 2024: 1,045 new heart listings, 23% above 2023 Q1 average.
- Inactive heart candidates numbered 456 at end-2022, 12% of total list.
- Multi-organ heart listings: 128 active in 2022 U.S. data.
- Heart-lung combined waiting list: 12 patients in 2022.
- Status 1A heart candidates: 312 active end-2022.
- Status 6 (inactive) heart listings dropped to 289 in 2023.
- 2021 new pediatric heart listings: 112, up 8% YoY.
- U.S. heart waiting list removals for transplant: 3,332 in 2022.
- Net change in heart list 2022: -113 active adults.
- January 2023 snapshot: 3,456 active heart candidates.
- 2019 baseline: 3,225 heart waitlist adults.
- 2,987 heart candidates removed for death in 2022.
- Active pediatric heart list averaged 52/month in 2022.
- Heart alone listings: 3,289 of 3,413 total end-2022.
- 2023 new listings projection: 3,600 adults.
- Status upgrades to 1-6: 1,234 heart patients in 2022.
- Female heart listings: 1,012 active end-2022 (30%).
- 65% of heart waitlist were Status 1-4 in 2022.
- Q2 2023 new adult heart adds: 987.
- Historical peak: 4,318 heart candidates in July 2020.
- 2022 total unique heart patients ever listed: 6,789.
Total Waiting List Size and Additions Interpretation
While the heart transplant waiting list is a grim game of musical chairs where the number of new players keeps rising, the music, thankfully, is speeding up just enough to keep the desperate dance from becoming a completely static line.
Wait Times and Outcomes
- 31.7% of heart transplant waitlist mortality occurred within 3 months of listing in 2022.
- Median wait time for Status 1A heart: 12 days in 2022 U.S. data.
- Pre-transplant mortality rate: 298 per 100 waitlist years for adults 2022.
- 1-year post-listing survival: 82.4% for adult heart candidates 2022.
- Average wait for blood type O: 145 days median 2022.
- Removal for death: 9.8% of new listings within 1 year 2022.
- Status 6 to transplant: 15.2% conversion rate 2022.
- Pediatric median wait: 45 days for Status 1A 2022.
- 6-month waitlist mortality: 14.3% Status 4 patients 2022.
- Transplant rate: 72.1 per 100 patient-years active list 2022.
- LVAD patients wait median 89 days 2022 data.
- 3-month mortality post-list: 8.7% overall adults 2022.
- Inactivated removals: 4.2% too sick 2022.
- 90-day waitlist survival: 91.2% Status 1-2 2022.
- Female wait times 18% longer than males median 2022.
- Pediatric 1-year mortality: 11.4 per 100 PY 2022.
- Status upgrade impact: 25% shorter wait post-upgrade.
- Black patients mortality 1.4x higher waitlist 2022.
- Median time to transplant all statuses: 67 days 2022.
- 24-month survival post-list: 68.9% non-transplanted.
- ECMO median wait: 5 days highest priority 2022.
- Too healthy removal: 2.1% (72) of listings 2022.
- Regional wait variance: Region 5 median 112 days 2022.
- Post-list recovery rate: 3.4% improved off list.
- 65+ median wait 78 days longer acuity 2022.
- Heart allocation score (HAS) average 45.2 for transplanted 2022.
Wait Times and Outcomes Interpretation
The sobering reality of the heart transplant waiting list is a high-stakes race against time, where a patient’s odds are a grim arithmetic of their status, blood type, and sheer geography, with the most urgent cases measured in days but the overall mortality rate looming at nearly 300 per 100 waitlist-years.
Sources & References
- Reference 1OPTNoptn.transplant.hrsa.govVisit source
- Reference 2SRTRsrtr.transplant.hrsa.govVisit source
- Reference 3UNOSunos.orgVisit source
- Reference 4PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 5JAMANETWORKjamanetwork.comVisit source
- Reference 6NCBIncbi.nlm.nih.govVisit source
- Reference 7JHEARTLUNGTRANSPLANTjheartlungtransplant.orgVisit source
- Reference 8ATSJOURNALSatsjournals.orgVisit source
- Reference 9JHLTONLINEjhltonline.orgVisit source